1. Hyperglycemia during first-line R-CHOP or dose adjusted R-EPOCH chemotherapy for non-Hodgkin lymphoma is prevalent and associated with chemotherapy alteration – a retrospective study. Issue 8 (3rd August 2018) Authors: Lamar, Zanetta S.; Dothard, Andrew; Kennedy, LeAnne; Isom, Scott; Robinson, Mac; Vaidya, Rakhee; Hurd, David; McClain, Donald; Lesser, Glenn Journal: Leukemia & lymphoma Issue: Volume 59:Issue 8(2018) Page Start: 1871 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗